InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Kisner Daniel l, Director. Officer active across 2 companies, notably Zynerba Pharmaceuticals, Inc.. Cumulatively, 8 filings have been published. History available since 3 August 2021. The latest transaction was disclosed on 11 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
KISNER DANIEL L is an Administrateur and appears in 8 filings. The sampled filings run from 2021-08-05 to 2026-02-10 and the most frequent transaction nature is Attribution, with buy and sell amounts shown as EUR 0 in the sampled filings.